$ARCC

ARES CAPITAL CORP (ARCC): Entry into a Material Definitive Agreement

ARES CAPITAL CORP (ARCC) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement. On September 15, 2026 Ares Capital Corporation (the “Company”) and U.S. Bank Trust Company, National Association (the “Trustee”), entered into a Seventh Supplemental Indenture (the “Seventh Supplemental Indenture”) to the Ind

Original reporting
Published Sep 15, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 8:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$ARCC
Neutral
high confidence
Mentioned
$ARCC
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ARCCNeutralHigh
01

Why it matters

The $750 M raise improves liquidity but adds debt; investors will watch credit metrics and the floating‑rate exposure from the swap.

02

Market read

Primary disclosure of a sizable debt issuance; relevant for fixed‑income and business‑development sector traders.

03

What to watch

The interest‑rate swap converting fixed to floating exposure could expose ARCC to rate volatility.

Relevance 6/10Novelty 9/10Timing: September 15, 2026 (filing day)

Background

Ares Capital Corp (ARCC) is a business‑development company that provides financing to middle‑market companies. The 8‑K details a new senior note offering and related interest‑rate swap.

Company-level read

Ticker impact

$ARCCNeutralHigh confidence
Context

ARCC filed an 8‑K announcing a $750 million issuance of 6.250% senior notes due 2033.

Expected impact

Potential short‑term price dip as investors price in higher debt, followed by stabilization if proceeds improve earnings.

Evidence & confidence

Large primary issuance is material and fresh; market typically reacts to new senior note offerings with modest volatility.

Market effects

May set a pricing benchmark for other business‑development companies issuing senior notes.

Limited to U.S. business‑development and specialty finance sector.

Low; primarily affects ARCC and its investors.

Counterpoint

If the proceeds are efficiently deployed, the added leverage could boost returns and support a price rally.

Key entities

  • U.S. Bank Trust Company, National Association

    Serves as trustee for the new senior notes.

  • JPMorgan Chase Bank, N.A.

    Provides the interest‑rate swap to convert fixed interest to floating SOFR‑based payments.

Related articles

$ARCCMed

Ares Leads $2.2 Billion Healthcare Loan

Ares Management Corp. is leading a $2.2 billion loan to MedImpact Holding Inc. to finance its acquisition of Medical Card System, Inc. The second-lien loan may pay at least 8% over the baseline rate. Ares manages $671 billion in assets and recently reported $708 billion in non-accruing loans. MedImpact serves 20 million customers and processes $40 billion in pharmacy transactions annually.

$ARCCMed

Ares Capital Q2 Earnings Call Highlights

Management expects industry credit conditions to continue normalizing toward longer-term averages, though it said performance differences among managers have widened. Schnabel said Ares Capital added four investments to non-accrual during the quarter, but the companies were in unrelated businesses and did not indicate a sector-specific trend.